The Role of Autologous Stem Cell Transplant in Ultra-High-Risk Myeloma: Do the Ends Still Justify the Means?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Role of Autologous Stem Cell Transplant in Ultra-High-Risk Myeloma: Do the Ends Still Justify the Means?

Published:2023-12 Issue:12 Volume:29 Page:727-729
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Paul Barry

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference29 articles.

1. Remarks on the pathology of mollities ossium; with cases;Solly;Medico-chirurgical transactions,1844

2. IMWG consensus on risk stratification in multiple myeloma;Chng;Leukemia,2014

3. Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group;Sonneveld;Blood, The Journal of the American Society of Hematology,2016

4. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management;Rajkumar;American journal of hematology,2022

5. Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis;Derman;Blood cancer journal,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP